Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Biotechnology Start-Up Psylo Wins Hello Tomorrow APAC Deep Tech Competition in Singapore 2023-10-31 15:42
iNtRON, Executes Evaluation License and Option Agreement for SAL200 2023-10-31 12:20
CStone Announces NMPA Approval of Sugemalimab for Patients with Relapsed or Refractory Extranodal NK/T-cell Lymphoma, the First Anti-PD-1/PD-L1 mAb Approved for this Indication 2023-10-31 10:16
AffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery 2023-10-31 09:35
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC 2023-10-31 07:00
LifeSpan Vision Ventures Invests in NaNotics 2023-10-31 02:26
WuXi AppTec Continued Solid Growth in the First Three Quarters of 2023 on Top of an Exceptionally Strong Year in 2022, with Profit Growth Continuously Exceeding Revenue Growth 2023-10-30 20:01
Aquinnah Pharmaceuticals Advances Oral Small Molecule Program Targeting Alzheimer's and Other Tauopathy Diseases 2023-10-30 19:00
First Patient Enrolled in Phase III Clinical Trial of Boan Biotech's Nivolumab Injection 2023-10-30 14:51
Henlius Announces NMPA Approvals of Two ADC Candidates for IND 2023-10-27 20:16
Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India 2023-10-27 19:47
Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India 2023-10-27 19:13
Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia 2023-10-26 22:49
Clarity and PSI kick off SAR-bisPSMA Phase III 2023-10-26 21:00
YS Biopharma Announces Receipt of Nasdaq Notice 2023-10-26 20:30
HanAll Biopharma Reports Third Quarter 2023 Financial Results and Provides a Business Update 2023-10-26 19:00
Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China 2023-10-26 18:33
Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA 2023-10-26 18:18
Bridge Biotherapeutics Announces Positive Recommendation from the Independent Data Monitoring Committee of the BBT-877 Phase 2a Study in Idiopathic Pulmonary Fibrosis 2023-10-26 07:00
First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe 2023-10-25 21:15
1 72 73 74 75 76 451